Regenxbio Inc (STU:RB0)
€ 9.45 0.1 (1.07%) Market Cap: 469.56 Mil Enterprise Value: 307.28 Mil PE Ratio: 0 PB Ratio: 1.65 GF Score: 65/100

Q4 2021 Regenxbio Inc Earnings Call Transcript

Mar 01, 2022 / 09:30PM GMT
Release Date Price: €23.7 (+3.22%)
Operator

Thank you for joining Q4 2021 REGENXBIO Inc. Earnings Conference Call.

(Operator Instructions)

As a reminder, today's call is being recorded. I'll now turn the call over to your host today, Patrick Christmas, Chief Legal Officer with REGENXBIO Bio. Sir, please go ahead.

Patrick J. Christmas
REGENXBIO Inc. - Chief Legal Officer

Good afternoon, and thank you for joining us today. With us today are Ken Mills, REGENXBIO's President and Chief Executive Officer; Dr. Steve Pakola, our Chief Medical Officer; and Vit Vasista, our Chief Financial Officer. Earlier this afternoon, REGENXBIO released financial and operating results for the fourth quarter and full year ended December 31, 2021. The press release reporting our financial results is available on our website at www.regenxbio.com.

Today's conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot